Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
HYPERION THERAPEUTICS INC (HPTX) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/09/2015 8-K/A Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Agreement and Plan of Merger, by and among Horizon Pharma, Inc., Ghrian Acquisition Inc. and Hyperion Therapeutics, Inc"
08/07/2014 8-K/A Financial Statements and Exhibits
Docs: "Consent of Independent Accountants, Kesselman & Kesselman, Israel (a member firm of PricewaterhouseCoopers International Limited)",
"The historical audited financial statements of Andromeda Biotech Ltd. as of and for the years ended December 31, 2013 and 2012",
"Unaudited Pro Forma Condensed Combined Balance Sheet as of March 31, 2014; and Unaudited Pro Forma Condensed Combined Statements of Operations for the three months ended March 31, 2014 and the year ended December 31, 2013"
08/12/2013 8-K/A Financial Statements and Exhibits
Docs: "Consent of Ernst & Young LLP",
"Consent of PricewaterhouseCoopers LLP",
"Audited Statements of Assets Acquired as of December 31, 2012 and December 31, 2011, Audited Statements of Revenues and Direct Expenses for the period from December 11, 2012 through December 31, 2012, the period from January 1, 2012 through December 10, 2012, and the year ended December 31, 2011, Unaudited Statement of Assets Acquired as of March 31, 2013, and Unaudited Statements of Revenues and Direct Expenses for the three months ended March 31, 2013 and 2012",
"Unaudited Pro Forma Condensed Combined Balance Sheet as of March 31, 2013 and Unaudited Pro Forma Condensed Combined Statements of Operations for the three months ended March 31, 2013 and the year ended December 31, 2012"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy